FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

Publisher： Karger

E-ISSN： 1423-0151|23|5|478-481

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.23, Iss.5, 2014-03, pp. : 478-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clubbing and Hypertrophic Osteoarthropathy in Two Patients Taking Long-Term Bevacizumab for Metastatic Colorectal Cancer

By Pracht Marc

Journal of Gastrointestinal Cancer, Vol. 42, Iss. 3, 2011-09 ,pp. : 176-178

Springer Publishing Company

Access to resources Recommend Favorite

Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy

By Hosokawa Ayumu Sugiyama Toshiro Ohtsu Atsushi Doi Toshihiko Hattori Santa Kojima Takashi Yano Tomonori Minashi Keiko Muto Manabu Yoshida Shigeaki

Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-07 ,pp. : 533-538

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori -related peptic ulcer disease in Kashmir, India

By Shah Altaf

Indian Journal of Gastroenterology, Vol. 32, Iss. 1, 2013-01 ,pp. : 32-36

Springer Publishing Company

Access to resources Recommend Favorite